Changing or Retaining Direct Oral Anticoagulant After Ischemic Stroke Despite Direct Oral Anticoagulant Treatment.
Shin-Yi LinYun-Tsz LiaoSung-Chun TangChing-Ching Claire LinChi-Chuan WangPublished in: Journal of the American Heart Association (2024)
Changing prestroke DOAC does not reduce the risk of recurrent cerebral ischemia in patients with atrial fibrillation who develop IS during DOAC therapy. However, future studies should continue to observe the potential trends of increased intracranial hemorrhage risk.
Keyphrases
- cerebral ischemia
- atrial fibrillation
- direct oral anticoagulants
- venous thromboembolism
- subarachnoid hemorrhage
- blood brain barrier
- brain injury
- current status
- stem cells
- case control
- human health
- mesenchymal stem cells
- bone marrow
- cell therapy
- risk assessment
- optic nerve
- replacement therapy
- optical coherence tomography